STAT3 and breast carcinoma: piR-2158 affects breast cancer biology via the targeting of IL11, leading to lower phosphorylation of STAT3 and impairment of JAK/STAT3 pathway, responsible for the dysregulation of angiogenesis and self-renewal of breast CSC [81].